Micro-/nano-plastics accentuate Parkinson's Disease-relevant phenotypes in a Drosophila model
Abstract
Micro- and nano-plastic (MNP) particles are a ubiquitous environmental contaminant that are increasingly bioaccumulating in human tissues, particularly the brain. MNPs induce mitochondrial defects, oxidative stress, inflammatory responses and neurotoxicity in cellular and organismal models. This raises the possibility that MNP exposure could cause or exacerbate neurological conditions associated with these pathological phenomena. Parkinsons Disease (PD), a common movement disorder characterised by degeneration of striatal dopaminergic neurons, and associated with mitochondrial dysfunction, represents such a condition. We therefore hypothesised that MNP exposure might interact with PD risk mutations affecting mitochondrial fidelity. We used a fruit fly model of PRKN-dependent PD associated with defects in mitophagy, a mitochondrial quality control pathway, to test this hypothesis. We found that ingestion of MNPs at concentrations tolerated by wild-type controls selectively enhanced PD-relevant phenotypes - including progressive dopaminergic neurodegeneration, movement defects, and sleep disruption - in this model of PD. Our data suggest that defects in mitochondrial quality control can increase vulnerability to MNP exposure, and more broadly, that MNPs may synergistically interact with existing genetic risk factors to worsen neurological disease.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Brain lipidomics identifies mitochondrial redox dysfunction and metabolic trade-offs associated with Parkinsons disease-like pathology induced by Nanoplastics exposure
Priya Rathor, Ashutosh Tiwari, … Ratnasekhar Ch·Free Radical Biology and MedicinePeer-reviewed·Mar 10, 2026
- Biotin rescues manganese-induced Parkinson's disease phenotypes and neurotoxicity
Yunjia Lai, Pablo Reina-Gonzalez, … Souvarish Sarkar·bioRxiv·Nov 21, 2023
- Parkinson's disease-related Miro1 mutation induces mitochondrial dysfunction and loss of dopaminergic neurons in vitro and in vivo
Axel Chemla, Giuseppe Arena, … Cláudia Saraiva·BrainPeer-reviewed·Feb 5, 2025
- Developmental exposure to the Parkinson's disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice
S. Boyd, Nathan C. Kuhn, … Alison I. Bernstein·Toxicological SciencesPeer-reviewed·Aug 22, 2023
- Parkinsonism Reversal and Dopaminergic Resilience: Lessons from a Rotenone-induced Parkinson's Disease Model
Prince Joshi, Fan Fan, Xuelin Lou·bioRxiv·Dec 23, 2025
- Comparative Proteomic Analysis of Environmental and Genetic Models of Parkinsons Disease Highlights the Role of Purine Metabolism.
Pablo Reina-Gonzalez, Müberra Fatma Cesur, … Souvarish Sarkar·bioRxiv·Feb 4, 2026